Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

GLG News by Biopharmaceutical Reimbursement Experts (EU)

David Sykes, Principal

David SykesPrincipalPRMA Consulting Ltd. What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Exubera - approvable is no longer reimbursable

October 24, 2007

Pfizer Abandons Exubera, Posts 77% Earnings Decline | online.wsj.com

Exubera is the first major product to fail primarily due to Pfizer's inability to convince payors of it's value for money There is now significant additional risk in achieving market access after regulatory approval. Pricing and reimbursement decisions will play an increasingly important role in the commercial success of companies going forward.

Page : 11 to 1 of 1

Leading institutions connect with members of the Healthcare councils through GLG

Most Popular Healthcare News